These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 34605157

  • 1. Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
    Heinemann M, Liwinski T, Adam R, Berenguer M, Mirza D, Malek-Hosseini SA, Heneghan MA, Lodge P, Pratschke J, Boudjema K, Paul A, Zieniewicz K, Fronek J, Mehrabi A, Acarli K, Tokat Y, Coker A, Yilmaz S, Karam V, Duvoux C, Lohse AW, Schramm C, all the other contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA).
    Am J Transplant; 2022 Feb; 22(2):626-633. PubMed ID: 34605157
    [Abstract] [Full Text] [Related]

  • 2. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM.
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [Abstract] [Full Text] [Related]

  • 3. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
    Jadaun SS, Mehtani R, Hasnain A, Bhatia S, Moond V, Kumar M, Kuhad V, Singh S, Agarwal S, Gupta S, Saigal S.
    Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
    [Abstract] [Full Text] [Related]

  • 4. Living vs deceased donor liver transplantation in cholestatic liver disease: An analysis of the OPTN database.
    Ziogas IA, Alexopoulos SP, Matsuoka LK, Geevarghese SK, Gorden LD, Karp SJ, Perkins JD, Montenovo MI.
    Clin Transplant; 2020 Oct; 34(10):e14031. PubMed ID: 33427333
    [Abstract] [Full Text] [Related]

  • 5. Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases: An intention-to-treat analysis.
    Jones O, Claasen MPAW, Ivanics T, Choi WJ, Gavaria F, Rajendran L, Ghanekar A, Hirschfield G, Gulamhusein A, Shwaartz C, Reichman T, Sayed BA, Selzner M, Bhat M, Tsien C, Jaeckel E, Lilly L, McGilvray ID, Cattral MS, Selzner N, Sapisochin G.
    Liver Transpl; 2024 Aug 01; 30(8):785-795. PubMed ID: 38619393
    [Abstract] [Full Text] [Related]

  • 6. Longterm Survival After Liver Transplantation for Autoimmune Hepatitis: Results From the European Liver Transplant Registry.
    Heinemann M, Adam R, Berenguer M, Mirza D, Malek-Hosseini SA, O'Grady JG, Lodge P, Pratschke J, Boudjema K, Paul A, Zieniewicz K, Fronek J, Weiss KH, Karam V, Duvoux C, Lohse A, Schramm C, all the other contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA).
    Liver Transpl; 2020 Jul 01; 26(7):866-877. PubMed ID: 32112516
    [Abstract] [Full Text] [Related]

  • 7. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    Trivedi PJ, Scalera I, Slaney E, Laing RW, Gunson B, Hirschfield GM, Schlegel A, Ferguson J, Muiesan P.
    J Hepatol; 2017 Nov 01; 67(5):957-965. PubMed ID: 28690174
    [Abstract] [Full Text] [Related]

  • 8. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A.
    Ann Surg; 2015 Sep 01; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry.
    Egawa H, Ueda Y, Ichida T, Teramukai S, Nakanuma Y, Onishi S, Tsubouchi H.
    Am J Transplant; 2011 Mar 01; 11(3):518-27. PubMed ID: 21219581
    [Abstract] [Full Text] [Related]

  • 10. Renal Dysfunction After Liver Transplantation: Effect of Donor Type.
    Kollmann D, Neong SF, Rosales R, Hansen BE, Sapisochin G, McCluskey S, Bhat M, Cattral MS, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M, Wong FSH, Selzner N.
    Liver Transpl; 2020 Jun 01; 26(6):799-810. PubMed ID: 32189415
    [Abstract] [Full Text] [Related]

  • 11. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE, Perkins JD, Reyes JD, Montenovo MI.
    Liver Transpl; 2019 Apr 01; 25(4):580-587. PubMed ID: 29637730
    [Abstract] [Full Text] [Related]

  • 12. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.
    Kashyap R, Mantry P, Sharma R, Maloo MK, Safadjou S, Qi Y, Jain A, Maliakkal B, Ryan C, Orloff M.
    J Gastrointest Surg; 2009 Aug 01; 13(8):1480-6. PubMed ID: 19430850
    [Abstract] [Full Text] [Related]

  • 13. Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation.
    Choudhary NS, Saigal S, Thummala S, Saraf N, Rastogi A, Bhangui P, Srinivasan T, Yadav SK, Nundy S, Soin AS.
    J Clin Exp Hepatol; 2020 Aug 01; 10(5):442-447. PubMed ID: 33029052
    [Abstract] [Full Text] [Related]

  • 14. Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.
    Anouti A, Patel MS, VanWagner LB, Lee WM, Asrani SK, Mufti AR, Rich NE, Vagefi PA, Shah JA, Kerr TA, Pedersen M, Hanish S, Singal AG, Cotter TG.
    Liver Transpl; 2024 Jan 01; 30(1):72-82. PubMed ID: 37490432
    [Abstract] [Full Text] [Related]

  • 15. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database.
    Kashyap R, Safadjou S, Chen R, Mantry P, Sharma R, Patil V, Maloo M, Ryan C, Marroquin C, Barry C, Ramaraju G, Maliakkal B, Orloff M.
    J Gastrointest Surg; 2010 Sep 01; 14(9):1362-9. PubMed ID: 20617395
    [Abstract] [Full Text] [Related]

  • 16. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul 01; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 17. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.
    Hepatology; 2011 Oct 01; 54(4):1313-21. PubMed ID: 21688284
    [Abstract] [Full Text] [Related]

  • 18. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center.
    Foley DP, Fernandez LA, Leverson G, Anderson M, Mezrich J, Sollinger HW, D'Alessandro A.
    Ann Surg; 2011 Apr 01; 253(4):817-25. PubMed ID: 21475025
    [Abstract] [Full Text] [Related]

  • 19. Variation in biliary complication rates following liver transplantation: implications for cost and outcome.
    Axelrod DA, Dzebisashvili N, Lentine KL, Xiao H, Schnitzler M, Tuttle-Newhall JE, Segev DL.
    Am J Transplant; 2015 Jan 01; 15(1):170-9. PubMed ID: 25534447
    [Abstract] [Full Text] [Related]

  • 20. Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
    Przybyszewski EM, Verna EC, Lobritto SJ, Martinez M, Vittorio JM, Fox AN, Samstein B, Kato T, Griesemer AD, Emond JC.
    Transplantation; 2018 Jun 01; 102(6):953-960. PubMed ID: 29369249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.